Variant CBH I polypeptides with reduced product inhibition
US9096871B2 · kind B2 · utility
0Cited by
1References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2011 |
| Grant date | Aug 4, 2015 |
| Priority date | — |
| Expiry date | Mar 12, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to variant CBH I polypeptides that have reduced product inhibition, and compositions, e.g., cellulase compositions, comprising variant CBH I polypeptides. The variant CBH I polypeptides and related compositions can be used in variety of agricultural and industrial applications. The present disclosure further relates to nucleic acids encoding variant CBH I polypeptides and host cells that recombinantly express the variant CBH I polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.